These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16186308)

  • 21. Insulin therapy in type 2 diabetes.
    Wyne KL; Mora PF
    Endocr Res; 2007; 32(3):71-107. PubMed ID: 18092196
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of hypoglycemic drugs on aspirin resistance in patients with diabetes mellitus.
    Ariturk Z; Islamoglu Y; Gündüz E; Yavuz C; Cil H; Tekbas E; Soydinc S; Kaya H; Elbey MA
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):617-21. PubMed ID: 22774402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of oral antidiabetics and insulin on lipids and coronary heart disease in non-insulin-dependent diabetes mellitus.
    Hanefeld M; Temelkova-Kurktschiev T; Köhler C
    Ann N Y Acad Sci; 1997 Sep; 827():246-68. PubMed ID: 9329759
    [No Abstract]   [Full Text] [Related]  

  • 24. JAMA patient page. Starting insulin treatment for diabetes.
    Jin J
    JAMA; 2014 Jun; 311(22):2347. PubMed ID: 24915279
    [No Abstract]   [Full Text] [Related]  

  • 25. How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?
    Koenen C
    Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):E1. PubMed ID: 18806804
    [No Abstract]   [Full Text] [Related]  

  • 26. When diet fails: insulin and oral hypoglycemic agents as alternatives for the management of gestational diabetes mellitus.
    Langer O
    J Matern Fetal Neonatal Med; 2002 Apr; 11(4):218-25. PubMed ID: 12375674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Insulin or insulin + oral hypoglycemic drugs in the treatment of type 2 diabetes difficult to compensate metabolically?].
    Carta Q; Trovati M; Dani F; Caselle MT; Vitali S; Cavalot F; Rocca G; Cantino G; Mularoni E; Libertucci D
    Minerva Endocrinol; 1984; 9(2):241-5. PubMed ID: 6390138
    [No Abstract]   [Full Text] [Related]  

  • 28. Insulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysis.
    Schwartz S; Sievers R; Strange P; Lyness WH; Hollander P;
    Diabetes Care; 2003 Aug; 26(8):2238-43. PubMed ID: 12882842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Switching from an oral regimen to insulin in diabetes.
    Perry M
    Community Nurse; 2000 May; 6(4):27-8. PubMed ID: 12778520
    [No Abstract]   [Full Text] [Related]  

  • 30. [Inefficacy of oral antidiabetics: failure or natural history of diabetes?].
    Schönenweid C
    Rev Med Suisse Romande; 1995 Sep; 115(9):671-3. PubMed ID: 7481353
    [No Abstract]   [Full Text] [Related]  

  • 31. [Insulin and oral antidiabetic drugs. How to combine them in type 2 diabetes?].
    Lotz N
    MMW Fortschr Med; 2000 May; 142(18):45-8. PubMed ID: 10851870
    [No Abstract]   [Full Text] [Related]  

  • 32. [Renewal of oral therapy for diabetes mellitus after secondary failure].
    Guberman D
    Harefuah; 1989 Nov; 117(9):240-1. PubMed ID: 2693275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral hypoglycaemic agents. When, how and why.
    Harris P; Colagiuri S
    Aust Fam Physician; 1997 Apr; 26(4):391-6. PubMed ID: 9115112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The sulfanilamide resistance of patients with type-2 diabetes mellitus].
    Gendeleka GF; Lakiza VV
    Lik Sprava; 1993 Apr; (4):51-6. PubMed ID: 8209448
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
    Hausmann M; Dellweg S; Osborn C; Heinemann L; Buchwald A; Rosskamp R; Genova P; Heise T
    Diabetes Obes Metab; 2006 Sep; 8(5):574-80. PubMed ID: 16918593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Short-term intensive insulin therapy as a method of overcoming secondary failure of sulfonylureas in patients with type 2 diabetes (non-insulin-dependent)].
    Jedynasty K; Kasperska-Czyzykowa T; Stepień K; Nowaczyk R
    Pol Arch Med Wewn; 1998 Jun; 99(6):442-51. PubMed ID: 10085698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents.
    Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P
    Diabetes Technol Ther; 2004 Feb; 6(1):1-8. PubMed ID: 15000763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Which treatment can be proposed to a diabetic patient presenting with secondary failure of oral antidiabetics?].
    Blanc MH; Galtier-Dereure F; Parer-Richard C; Bringer J; Jaffiol C
    Rev Med Suisse Romande; 1993 Nov; 113(11):955-61. PubMed ID: 8272722
    [No Abstract]   [Full Text] [Related]  

  • 39. Bedtime intermediate-acting insulin in the treatment of secondary failure to oral hypoglycemic agents.
    Chuang LM; Lu C; Su RJ; Wu HP; Tai TY; Lin BJ
    J Formos Med Assoc; 1992 Feb; 91(2):185-9. PubMed ID: 1364216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [What is new in the treatment of diabetes mellitus?].
    Gain T
    Krankenpfl J; 2000 Oct; 38(9-10):328-31. PubMed ID: 11194350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.